The Treatment of ADHD in Children

The Treatment of ADHD in Children

The conversation surrounding the treatment of Attention-Deficit/Hyperactivity Disorder for kids has shifted from simply focusing on medication to a more nuanced debate over its timing, necessity, and long-term effects. Stimulants like Adderall and Ritalin remain the standard for many doctors to treat young patients, but recent research highlights a new tension: are we prescribing these drugs too frequently to young children, and is there real danger in treatment? The Preschool Gap: Bypassing Therapy for Pills led by Stanford Medicine reveals a concerning trend among ADHD child patients. Clinical guidelines from the American Academy of Pediatrics recommend that children ages 4 and 5 receive six months of behavior therapy before starting medication, however the reality for many families is often different. The study found that more than 40% of preschoolers diagnosed with ADHD are prescribed medication within just 30 days of their diagnosis. This approach leaves parents with a lack of behavior management, which has been shown to not only reduce symptoms in their child, but also strengthen their bond. Experts suggest that the rush to medicate may be driven by a lack of accessible therapy or the immediate pressure families face when a child’s behavior threatens their enrollment in daycare or preschool. The lack of additional resources, especially for underprivileged families, could be a driving factor.

For many parents, there is also the fear of permanent changes to a child’s developing brain or body as a result of giving ADHD medications to their children. According to the Child Mind Institute, decades of research have provided reassurance. Stimulants work by leveling out dopamine and norepinephrine to match the levels of those without ADHD. These chemicals are essential for focus, and while side effects like decreased appetite and sleep issues are common, they are generally manageable through dosage adjustments. One of the most persistent concerns by parents was delayed growth, however it appears to be temporary. Studies indicate that while children may lag slightly in height or weight during the first year of treatment, they typically catch up to those in their age group by the second or third year on medication. Furthermore, there is no evidence that taking these medications as prescribed leads to addiction; in fact, the opposite may be true. Research from Massachusetts General Hospital framed a compelling counter-argument to the fear of "over-medication". Their research suggests that delaying stimulant therapy may actually increase the risk of substance use disorders later in life.The MGH study found that youth who began stimulant therapy at age 9 or younger and continued it for several years were significantly less likely to misuse prescription stimulants or use illicit drugs like cocaine in later life. Those who started treatment after age 10 or had a shorter duration of therapy faced a much higher risk of substance misuse. Early, consistent management of ADHD symptoms can protect a child’s future, not harm it.

A review in PubMed Central (NCBI) points to the millions of children who remain under-treated, instead of over-medicated. The goal for clinicians and parents alike is to find a state of balance, where children feel properly supported and have the medication to regulate their system throughout their life. The most effective treatment for ADHD is a perfectly tailored plan; a combination of therapy, education, and monitored medical support which recognizes the child's specific developmental stage.